Spleen lymphocyte subpopulations in patients with Hodgkin's disease.

Authors

  • Benedita Rocha Memorial Sloan Kettering Cancer Center. New York. U.S.A. e Departamento de Imunologia. Faculdade de Ciencias Medicas de Lisboa
  • G. Munn Memorial Sloan Kettering Cancer Center. New York. U.S.A. e Departamento de Imunologia. Faculdade de Ciencias Medicas de Lisboa
  • Maria de Sousa Memorial Sloan Kettering Cancer Center. New York. U.S.A. e Departamento de Imunologia. Faculdade de Ciencias Medicas de Lisboa

DOI:

https://doi.org/10.20344/amp.4398

Abstract

Estudaram-se as populações linfocitária em bacos de 5 doentes com doença de Hodgkin e num individuo normal. Nos bacos patológicos observou-se um aumento do número de células null e uma diminuição da resposta ao mitogénio Concanavalina A, com manutenção da resposta a fitohemaglutinina. Por separação das células em gradientes de densidade isolou-se uma população celular incapaz de responder a Concanavalina A.

 

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Rocha B, Munn G, de Sousa M. Spleen lymphocyte subpopulations in patients with Hodgkin’s disease. Acta Med Port [Internet]. 1979 Oct. 30 [cited 2024 Nov. 16];1(5):551-9. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/4398

Issue

Vol. 1 No. 5 (1979): Setembro-Outubro

Section

Arquivo Histórico

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC